Holen Sie sich die Stockscreener-App
2.9488
14.29%
0.3688
Schlusskurs vom Vortag:
$2.58
Offen:
$2.6084
24-Stunden-Volumen:
1,021
Relative Volume:
0.06
Marktkapitalisierung:
$106.27M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-1.1703
EPS:
-2.5197
Netto-Cashflow:
-
1W Leistung:
-9.82%
1M Leistung:
+51.22%
6M Leistung:
-76.87%
1J Leistung:
-71.06%
1-Tages-Spanne:
$2.6084
$2.6084
1-Wochen-Bereich:
$2.50
$3.44
52-Wochen-Spanne:
$1.85
$17.48
Adlai Nortye Ltd Adr Stock (ANL) Company Profile
Firmenname
Adlai Nortye Ltd Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie ANL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| ANL | 2.6084 | 106.27M | 0 | 0 | 0 | -2.5197 |
| VRTX | 447.00 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 739.78 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 590.30 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 249.57 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 103.41 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Adlai Nortye Ltd Adr Aktie (ANL) Neueste Nachrichten
Adlai Nortye shares hold Buy rating by H.C. Wainwright on oncology programs - Investing.com
Adlai Nortye stock strengthened by oncology trial results, H.C. Wainwright keeps at Buy list - Investing.com
ANL stock touches 52-week low at $1.85 amid sharp annual decline - Investing.com
ANL stock touches 52-week low at $1.85 amid sharp annual decline By Investing.com - Investing.com South Africa
Adlai Nortye stock plunges to 52-week low of $1.89 - Investing.com
Adlai Nortye stock plunges to 52-week low of $1.89 By Investing.com - Investing.com Canada
Adlai Nortye Ltd. Sponsored ADR (ANL) Loses -33.06% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
H.C. Wainwright sees upside in Adlai Nortye stock amid robust oncology pipeline - Investing.com
Adlai Nortye Reports Strong 2024 Mid-Year Results - TipRanks
Adlai Nortye releases unaudited H1 2024 results, adds new director - Investing.com
Adlai Nortye Announces Executive Leadership Transition - TipRanks
Closing Bell Recap: Adlai Nortye Ltd. ADR (ANL) Ends at 7.70, Reflecting a -6.78 Downturn – DWinneX - The Dwinnex
Adlai Nortye to Unveil Cancer Drug Data at ASCO 2024TipRanks.com - TipRanks
Adlai Nortye Ltd. to Present Encouraging Data of the Combination of AN0025 and Definitive Chemoradiotherapy (dCRT) at ASCO 2024 - GlobeNewswire Inc.
Are Medical Stocks Lagging Adlai Nortye Ltd. Sponsored ADR (ANL) This Year? - Yahoo Finance Australia
Why Take-Two Interactive Software Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session - Markets Insider
symbol__ Stock Quote Price and Forecast - CNN
Adlai Nortye (ANL) Stock Price, News & Analysis - MarketBeat
IPO Update: Adlai Nortye Readies $72 Million U.S. IPO (Pending:ANL) - Seeking Alpha
Finanzdaten der Adlai Nortye Ltd Adr-Aktie (ANL)
Es liegen keine Finanzdaten für Adlai Nortye Ltd Adr (ANL) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.42%
0.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):